Previous studies have found that CDK11 is up-regulated in breast cancer50, multiple myeloma51, osteosarcoma52, and esophageal squamous cell carcinoma53, and down-regulation of CDK11 arrests growth and induces apoptosis in these cancer cells, thus suggesting that CDK11 acts as an oncogene. This evidence concerns the gene CDK19 and cancer.